tiprankstipranks
Nath Bio-Genes (India) Ltd. (IN:NATHBIOGEN)
:NATHBIOGEN
India Market
NATHBIOGEN
Nath Bio-Genes (India) Ltd.
RESEARCH TOOLSreports
Want to see IN:NATHBIOGEN full AI Analyst Report?

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Financial Statements

3 Followers

Nath Bio-Genes (India) Ltd. Financial Overview

Nath Bio-Genes (India) Ltd.'s market cap is currently ₹3.26B. The company's EPS TTM is ₹21.68; its P/E ratio is 6.15; and it has a dividend yield of 1.26%. Nath Bio-Genes (India) Ltd. is scheduled to report earnings on May 4, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 4.45B₹ 3.65B₹ 2.48B₹ 3.01B₹ 2.78B
Gross Profit₹ 2.04B₹ 2.29B₹ 1.03B₹ 1.67B₹ 1.54B
Operating Income₹ 484.75M₹ 459.82M₹ 477.02M₹ 1.73B₹ 1.38B
EBITDA₹ 524.39M₹ 497.98M₹ 536.39M₹ 488.91M₹ -497.06M
Net Income₹ 416.30M₹ 386.00M₹ 396.19M₹ 350.11M₹ -673.38M
Balance Sheet
Cash & Short-Term Investments₹ 759.95M₹ 888.99M₹ 774.10M₹ 379.90M₹ 41.68M
Total Assets₹ 10.97B₹ 10.26B₹ 8.80B₹ 7.93B₹ 7.42B
Total Debt₹ 1.39B₹ 1.23B₹ 1.10B₹ 1.05B₹ 929.59M
Net Debt₹ 625.06M₹ 336.01M₹ 329.41M₹ 672.17M₹ 887.91M
Total Liabilities₹ 4.17B₹ 3.82B₹ 2.70B₹ 2.20B₹ 2.00B
Stockholders' Equity₹ 6.80B₹ 6.44B₹ 6.10B₹ 5.73B₹ 5.42B
Cash Flow
Free Cash Flow₹ -250.40M₹ 96.61M₹ 478.18M₹ 358.18M₹ -39.70M
Operating Cash Flow₹ -220.35M₹ 175.81M₹ 745.94M₹ 383.67M₹ 170.46M
Investing Cash Flow₹ -30.69M₹ -39.62M₹ -274.01M₹ -28.84M₹ -198.66M
Financing Cash Flow₹ 122.00M₹ -21.30M₹ -77.78M₹ -16.68M₹ -222.27M
Currency in INR

Nath Bio-Genes (India) Ltd. Earnings and Revenue History

Income Statement >

Nath Bio-Genes (India) Ltd. Debt to Assets

Balance Sheet >

Nath Bio-Genes (India) Ltd. Cash Flow

Cash Flow >

Nath Bio-Genes (India) Ltd. Forecast EPS vs Actual EPS

Earnings >